Patents by Inventor Joerg Willuda

Joerg Willuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090081207
    Abstract: The present invention relates to recombinant human or humanized polypeptides which bind to ?5?1 integrin with high affinity and blocking function. Further, diagnostic and pharmaceutic applications of the potypeptides are disclosed.
    Type: Application
    Filed: May 23, 2007
    Publication date: March 26, 2009
    Inventors: ANDREAS MENRAD, JOERG WILLUDA, KLAUS BOSSLET, DIETER ZOPF, HEIKE PETRUL, STEFAN STEIDL, JOSEF PRASSLER, CORINNE PETIT-FRERE
  • Patent number: 7341722
    Abstract: The present invention relates to a method for stabilizing chimeric immunoglobulins or immunoglobulin fragments. Furthermore, the invention also provides a stabilized anti-EGP-2 scFv fragment.
    Type: Grant
    Filed: December 30, 2004
    Date of Patent: March 11, 2008
    Assignee: University of Zurich
    Inventors: Andreas Pluckthun, Annemarie Honegger, Joerg Willuda
  • Publication number: 20050234247
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Application
    Filed: January 31, 2005
    Publication date: October 20, 2005
    Inventors: Ulrich Klar, Joerg Willuda, Andreas Menrad, Klaus Bosslet